Evidence map›Paper›PMID 28982110›Full record

GuidelineBritish journal of cancer2017

International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.

Pieter-Jan van Dam, Eric P van der Stok, Laure-Anne Teuwen, Gert G Van den Eynden, Martin Illemann, Sophia Frentzas, Ali W Majeed, Rikke L Eefsen, Robert R J Coebergh van den Braak, Anthoula Lazaris and 22 more

2 registry-linked trialsOpen access · hybridAbstract readPractice Guideline
In one paragraph

Guideline in British journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 147 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
147citing papers in PubMed, 2 pooled it
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06779734 completednot on this mapstarted 2020, after this paper: background citation

Radiomic Features of Tumor and of Liver-Tumor Interface in Patients With Colorectal Liver Metastases. Identification of New Prognostic Biomarkers.

TypeobservationalSponsorIstituto Clinico HumanitasRan2020 to 2024Enrolled400ConditionsLiver Metastases From Colorectal Cancer (mCRC)
NCT07564908 active not recruitingnot on this mapstarted 2018, after this paper: background citation

Correlation and Heterogeneity of the Immune Microenvironment and Histopathological Growth Patterns in Resectable Colorectal Cancer Liver Metastases

TypeobservationalSponsorMeng QiuRan2018 to 2030Enrolled64ConditionsColorectal NeoplasmsArmsFormalin-fixed, paraffin-embedded (FFPE) sections of colorectal cancer liver metastases were stained with hematoxylin and eosin (H&E) and Multiplex immunohistochemistry (mIHC) staining.
3 · Its place in the literature

Who cites it

147 citing papers in PubMed, 2 syntheses or guidelines pooled it, 228 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Liver metastases beyond classical imaging findings.Abdominal radiology (New York) · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

87 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 16 institutions in 8 countries.

Pieter-Jan van DamTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Eric P van der StokDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Laure-Anne TeuwenTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Gert G Van den EyndenTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Martin IllemannThe Finsen Laboratory, Rigshospitalet/BRIC, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark.
Sophia FrentzasTumour Biology Team, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Ali W MajeedHepatobiliary Surgery, Sheffield Teaching Hospitals, Sheffield, UK.
Rikke L EefsenDepartment of Oncology, Naestved Hospital, Naestved, Denmark.
Robert R J Coebergh van den BraakDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Anthoula LazarisDepartment of Surgery, Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Maria Celia FernandezDepartments of Surgery, Oncology and Medicine, McGill University and the McGill University Health Center Research Institute, Cancer Research Program, Montreal, QC, Canada.
Boris GaljartDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Ole Didrik LaerumThe Finsen Laboratory and Department of Radiation Biology, Copenhagen University Hospital, University of Copenhagen, Denmark.
Roni RayesDepartments of Surgery, Oncology and Medicine, McGill University and the McGill University Health Center Research Institute, Cancer Research Program, Montreal, QC, Canada.
Dirk J GrünhagenDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Michelle Van de PaerTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Yves SucaetDepartment of Pathology, Faculty of Medicine, Vrije Universiteit Brussel, Brussels, Belgium.
Hardeep Singh MudharDepartment of Histopathology, Royal Hallamshire Hospital, Sheffield, UK.
Michael SchvimerInstitute of Pathology, Sheba Medical Center, Tel Hashomer, Israel.
Hanna NyströmDepartment of Surgery, Department of Surgical and Perioperative Sciences, Umeå University, Umeå, Sweden.
Mark KockxHistoGeneX, Sint-Bavostraat 78-80, Antwerp 2610, Belgium.
Nigel C BirdDepartment of Oncology & Metabolism, University of Sheffield, Sheffield, UK.
Fernando Vidal-VanaclochaValencia Institute of Pathology, Catholic University of Valencia, Valencia, Spain.
Peter MetrakosDepartment of Surgery, Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Eve SimoneauDepartment of Surgery, Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.
Cornelis VerhoefDepartment of Surgical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Luc Y DirixTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Steven Van LaereTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
Zu-Hua GaoDepartment of Pathology and Oncology, McGill University, Montreal, QC, Canada.
Pnina BrodtDepartments of Surgery, Oncology and Medicine, McGill University and the McGill University Health Center Research Institute, Cancer Research Program, Montreal, QC, Canada.
Andrew R ReynoldsTumour Biology Team, Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK.
Peter B VermeulenTranslational Cancer Research Unit, GZA Hospitals (St Augustinus), Wilrijk-Antwerp, Belgium.
GZA Ziekenhuizen Campus Sint-Augustinus · BEMcGill University Health Centre · CAErasmus MC Cancer Institute · NLBreast Cancer Now · GBHistoGeneX (Belgium) · BEMcGill University · CANæstved Sygehus · DKRigshospitalet · DKRoyal Hallamshire Hospital · GBSheba Medical Center · ILSheffield Teaching Hospitals NHS Foundation Trust · GBUmeå University · SEUniversity of Copenhagen · DKUniversity of Sheffield · GBValencia Catholic University Saint Vincent Martyr · ESVrije Universiteit Brussel · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLiver metastases present with distinct histopathological growth patterns (HGPs), including the desmoplastic, pushing and replacement HGPs and two rarer HGPs. The HGPs are defined owing to the distinct interface between the cancer cells and the adjacent normal liver parenchyma that is present in each pattern and can be scored from standard haematoxylin-and-eosin-stained (H&E) tissue sections. The current study provides consensus guidelines for scoring these HGPs.

methodsGuidelines for defining the HGPs were established by a large international team. To assess the validity of these guidelines, 12 independent observers scored a set of 159 liver metastases and interobserver variability was measured. In an independent cohort of 374 patients with colorectal liver metastases (CRCLM), the impact of HGPs on overall survival after hepatectomy was determined.

resultsGood-to-excellent correlations (intraclass correlation coefficient >0.5) with the gold standard were obtained for the assessment of the replacement HGP and desmoplastic HGP. Overall survival was significantly superior in the desmoplastic HGP subgroup compared with the replacement or pushing HGP subgroup (P=0.006).

conclusionsThe current guidelines allow for reproducible determination of liver metastasis HGPs. As HGPs impact overall survival after surgery for CRCLM, they may serve as a novel biomarker for individualised therapies.

Indexed as

HumansLiver NeoplasmsNeoplasm Metastasis

Identifiers

PMID28982110
PMCPMC5680474
OpenAlexW2761998606

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.